Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | — | 2 | — | — | — | 2 |
Hodgkin disease | D006689 | — | C81 | — | 1 | — | — | — | 1 |
T-cell lymphoma | D016399 | — | — | — | 1 | — | — | — | 1 |
T-cell lymphoma peripheral | D016411 | — | — | — | 1 | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Cilmostim |
INN | cilmostim |
Description | Cilmostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108239 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EWL6971ETP (ChemIDplus, GSRS) |